SLAS Discovery

Papers
(The H4-Index of SLAS Discovery is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Outline and background for the EU-OS solubility prediction challenge176
POLARISED views and FRETting about probe modulation assays: Learning from High Throughput Screening70
Bioassay protocol metadata annotation: Proposed standards adoption54
FLECS technology for high-throughput screening of hypercontractile cellular phenotypes in fibrosis: A function-first approach to anti-fibrotic drug discovery54
Fluorescent probe for the identification of potent inhibitors of the macrophage infectivity potentiator (Mip) protein of Burkholderia pseudomallei40
Ex vivo discovery of synergistic drug combinations for hematologic malignancies38
Standards for reporting optical biosensor experiments (STROBE): Improving standards in the reporting of optical biosensor-based data in the literature36
Genetically encoded fluorogenic RNA-based bioluminescence resonance energy transfer (BRET) sensors for cellular imaging and target detection26
Protocol for 3D screening of lung cancer spheroids using natural products25
HTS driven by fluorescence lifetime detection of FRET identifies activators and inhibitors of cardiac myosin24
Magnetic 3D bioprinting of skeletal muscle spheroid for a spheroid-based screening assay24
Emerging drug discovery ecosystems18
Parallel in vitro ion channel and in vivo zebrafish assaying of elapid snake venoms following chromatographic separation of toxin components18
Single-plate kinome screening in live-cells to enable highly cost-efficient kinase inhibitor profiling17
Nanobodies: A Game-Changer in Cell-Mediated Immunotherapy for Cancer17
Temperature-related intensity change (TRIC)-based high throughput screening platform for the discovery of CHI3L1-targeted small molecules16
Role Of Vaccines Against COVID-19 Pandemic16
Repurposing drug screen for the identification of helicase inhibitors from viruses of pandemic concern16
0.064083099365234